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Somatic cell reprogramming has generated enormous interest after the first report by Yamanaka and his
coworkers in 2006 on the generation of induced pluripotent stem cells (iPSCs) from mouse fibroblasts.
Here we report the generation of stable iPSCs from mouse fibroblasts by recombinant protein transduc-
tion (Klf4, Oct4, Sox2, and c-Myc), a procedure designed to circumvent the risks caused by integration
of exogenous sequences in the target cell genome associated with gene delivery systems. The recombinant
proteins were fused in the frame to the glutathione-S-transferase tag for affinity purification and to the
transactivator transcription-nuclear localization signal polypeptide to facilitate membrane penetration
and nuclear localization. We performed the reprogramming procedure on embryonic fibroblasts from in-
bred (C57BL6) and outbred (ICR) mouse strains. The cells were treated with purified proteins four times,
at 48-h intervals, and cultured on mitomycin C treated mouse embryonic fibroblast (MEF) cells in com-
plete embryonic stem cell (ESC) medium until colonies formed. The iPSCs generated from the outbred
fibroblasts exhibited similar morphology and growth properties to ESCs and were sustained in an undif-
ferentiated state for more than 20 passages. The cells were checked for pluripotency-related markers (Oct4,
Sox2, Klf4, cMyc, Nanog) by immunocytochemistry and by reverse transcription–polymerase chain reac-
tion. The protein iPSCs (piPSCs) formed embryoid bodies and subsequently differentiated towards all three
germ layer lineages. Importantly, the piPSCs could incorporate into the blastocyst and led to variable
degrees of chimerism in newborn mice. These data show that recombinant purified cell-penetrating pro-
teins are capable of reprogramming MEFs to iPSCs. We also demonstrated that the cells of the generated
cell line satisfied all the requirements of bona fide mouse ESCs: form round colonies with defined bound-
aries; have a tendency to attach together with high nuclear/cytoplasmic ratio; express key pluripotency
markers; and are capable of in vitro differentiation into ecto-, endo-, and mesoderm, and in vivo chimera
formation.
Introduction
Somatic cells can be reprogrammed to induced plu-ripotent stem cells (iPSCs) by the introduction of plur-
ipotency related transcriptional factors OCT4, KLF4, SOX2,
and cMYC, as first reported by Yamanaka and his coworkers.1
Recently, there have been significant advances in iPSC tech-
nology, with iPSCs being generated in a broad range of
species, including human,1–4 mouse,1,5–7 rat,8 pig,9,10
sheep,11,12 and rabbit,13 and froma rangeof cell types, including
fibroblasts,14 terminally differentiated lymphocytes15 andother
blood cells, stomach and liver cells,16 neural progenitors,17
keratinocytes,18 melanocytes,19 and pancreatic b cells.20
A large number of these iPSC lines were generated by
retroviral transduction, which is a highly efficient and repro-
ducible method. However, in this process, small sequences of
the retroviral vector are integrated in the host genome along
with the genes coding for reprogramming factors. As a result,
these permanent insertions potentially increase the risk of
tumor formation.6,21
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To overcome the unwanted side effects resulting from
viral integration, a number of methods have been developed
to produce iPSC with potentially reduced risks:
(1) nonviral reprogramming, such as the PiggyBac22,23
and Sleeping Beauty24 transposon systems;
(2) nonintegrating genetic manipulation of cells, including
repeated plasmid transfection,25 transfection with
minicircle DNA vectors,25–28 reprogramming with
episomal vectors carrying the reprogramming fac-
tors,29 or the treatment of cells with nonintegrating
viruses, like Adeno-30–34 and Sendai virus35,36; and
(3) nongenetic treatments, including small molecules
translocating into the cells and interfering with differ-
ent signaling pathways,37–41 direct delivery of syn-
thetic mRNA,42,43 or reprogramming proteins.44–46
The disadvantage of the nonviral and nonintegrative
methods is their very low reprogramming efficiency com-
pared to viral transduction. Furthermore, the instability of
some of the nonintegrative systems (mRNA and plasmids)
means that multiple treatments are required, making the
entire reprogramming procedure laborious.47
Proteins can be delivered into cells both in vivo and in vitro
if they are fused in frame to cell-penetrating peptides (CPP)
or protein transduction domains.48 The advantage of repro-
gramming by protein transduction is that no genetic inte-
gration occurs; thus, allowing the generation of exogene-free
iPSC lines, which is an important safety advantage for hu-
man therapy. However, the reprogramming efficiency of
purified protein transduction is very low (< 0.05% of the cells
treated), which might be caused by the cellular uptake
mechanisms active in the process of internalization of the
CPP harboring proteins.
The aim of this study was to generate murine iPSCs by
purified recombinant protein transduction using a novel
approach that entirely replaces the gene delivery systems.
This strategy differs from other protein transduction sys-
tems44–46 as the four transcriptional factors (Oct4, Klf4, Sox2,
and cMyc) were fused to the transactivator transcription
(TAT) sequence, to the nuclear localization signal (NLS), and
to the glutathione-S-transferase (GST) sequence. The TAT
sequence is derived from the human immunodeficiency vi-
rus type 1 (HIV1) and it facilitates cell penetration of the
recombinant proteins.49 The NLS sequence promotes nuclear
localization,50 potentially decreasing the quantity of proteins
trapped in organelles. Finally, the GST sequence is used for
affinity purification.
Materials and Methods
Experimental procedures
All chemicals were from Sigma-Aldrich (St. Louis, MO).
The cell culture media and supplements were purchased
from Invitrogen Life Technologies (Carlsbad, CA), unless
otherwise specified. The protocols for animal care and
handling were approved by the Animal Experiments Com-
mittee of ABC (Godollo, Hungary) and the Animal Health
Authorities.
For more details, see Supplementary Materials and
Methods section (Supplementary Data are available online at
www.liebertpub.com/tec).
Results
Expression and purification of recombinant
reprogramming proteins
To generate the recombinant reprogramming proteins
Oct4, Klf4, Sox2, and c-Myc, we constructed the GST-tagged
recombinant transcriptional factors harboring a short peptide
sequence of the HIV trans-activator of Transcription protein
(TAT), and the NLS to direct the proteins into the nucleus
(Fig. 1A). The two sequences were separated by a short
linker to assure the flexibility of the protein structure.
All recombinant reprogramming proteins were produced
in Escherichia coli BL21 (DE3) bacteria, affinity purified, dia-
lyzed against phosphate-buffered saline, and sterilized by
filtration, and the aliquots were stored at - 80C. The puri-
fied proteins were visualized by SDS-PAGE and SimplyBlue
Safe Stain (Fig. 1B–F).
To verify the stability of the proteins after delivery, mouse
embryonic fibroblasts (MEFs) were transduced with 2mg
individual recombinant protein (Oct4, cMyc, Klf4 or Sox2).
The cells were fixed 12 and 24h after transduction, and
probed for the presence of recombinant proteins. A small
population of cells showed positive staining and proper
nuclear localization of the proteins (Fig. 1G and data not
shown).
Generation of PSCs by protein transduction
To generate iPSCs from mouse somatic cells, the cells were
subjected to four protein transduction cycles at 48-h intervals
(Fig. 2A), as described earlier.44,45 On day 9, the cells were
gently dissociated and transferred in mitomycin C-treated
feeder coated 10 cm dishes and cultured until ES-like colo-
nies appeared (around day 40). The colonies were picked and
expanded for further characterization. The iPSC line lost the
morphology characteristics of fibroblast cells (Fig. 2B, left
panel) and its morphology and growth dynamics (Fig. 2B,
middle panel) resembled natural, bona fide mouse embry-
onic stem cells (mESCs) (Fig. 2B, right panel), forming tight
round colonies, with large nucleus, and characterized by
high nucleus-to-cytoplasm ratio. To verify the undifferenti-
ated state of the generated piPSC line, H1 (piPS-H1), we first
assessed alkaline phosphatase (ALP) activity. The piPSC-H1
formed typical ES-like colonies and exhibited positive
staining for ALP (Fig. 2C, left panel). We were able to culture
the cells for more than 20 passages and the colonies re-
mained undifferentiated.
To increase the reprogramming efficacy, we also per-
formed experiments al low O2 level. The numbers of ES-like
colonies obtained under hypoxic conditions were higher
compared to the number of colonies obtained under atmo-
spheric conditions.
Verification of pluripotency gene expression
of the new piPSCs
For a more profound evaluation, we performed immu-
nocytochemical staining of the cells for the major plur-
ipotency markers SSEA1, Oct4, Klf4, Nanog, and Sox2 (Fig.
3A). The piPS-H1 line uniformly expressed the nuclear Oct4,
Klf4, Nanog, and Sox2 and a high proportion of cells showed
positive staining for the membrane marker SSEA1, similar to
the control ESC line (Supplementary Fig. S1).
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FIG. 2. Generation of protein induced pluripotent stem cells (piPSCs). (A) Transduction strategy: On day 0 (D0) 5 · 104 cells
were seeded in one well of a six-well plate. Twenty-four hour later the cells were treated with 8mg/mL purified protein
cocktail (Oct4 +Klf4+ Sox2 + cMyc) or purified GST as control in embryonic stem cell medium (EM). After 12 h incubation
with the proteins, the transduction medium was changed to normal EM. The protein treatment was repeated four times at 48-
h intervals. On day 9 (D9) the cells were transferred into mouse embryonic fibroblast (MEF)-coated dishes and cultured
further until embryonic stem cell (ESC)-like colonies appeared. The EM was refreshed every other day. (B) Morphology of
MEF, iPS, and ESCs: The morphology of the iPSCs, piPS-H1, (middle panel) during reprogramming changed from fibroblast
(left panel) morphology and progressively resembled the morphology observed for the control mouse ESCs (mESCs) (right
panel). (C) Alkaline phosphatase (ALP) staining: The expended piPSCs (left panel) grew in compact colonies similar to the
bona fide mESCs (right panel) and stained positive for ALP. Color images available online at www.liebertpub.com/tec
FIG. 1. Mouse recombinant transcriptional factors. (A) Schematic representation of glutathione-S-transferase (GST) tagged
fusion protein. Mouse transcriptional factors were fused to the N terminus of the GST tag followed by the transactivator
transcription-nuclear localization (TAT-NLS) polypeptide sequence to facilitate membrane penetration and nuclear locali-
zation. (B-F) Recombinant proteins were overexpressed in bacteria. The protein expression was induced by IPTG. The
proteins were affinity purified using glutathione-Sepharose 4B, dialyzed against phosphate-buffered saline (PBS). The pu-
rified proteins were concentrated and sterilized by filtration, and stored in PBS at - 80C. The proteins were visualized by
SDS-PAGE and SimplyBlue Safe Stain: GST (B), Oct4 (C), Klf4 (D), Sox2 (E), and cMyc (F). (G) The stability of transduced
recombinant Oct4 and Sox2 proteins. Twenty-four hours after transduction, mouse fibroblasts were fixed and probed for the
presence of proteins. Scale bar: 100mm. Color images available online at www.liebertpub.com/tec
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We also performed reverse-transcription polymerase
chain reaction analysis for an extended set of pluripotency
markers: OCT4, KLF4, SOX2, NANOG, FOXD3, E-RAS,
FBXO15, REX1, and DAX1. The piPS-H1 line expressed all
pluripotency markers similar to the control mESC (Fig. 3B) line.
Therefore, the derived piPS-H1 line displayed all features
specific to a PSC, based on morphology, growth rate, and
pluripotency marker expression.
To assess the stability of the piPS-H1 line, we verified the
pluripotencymarker expression by immunostaining over long-
term culture ( p> 20, generally the passage number was be-
tween 22–25). Even after 4–5 weeks’ culture, the piPS-H1 cells
still expressed the nuclear pluripotency markers Oct4, Sox2,
Nanog, and Klf4 and the membrane marker SSEA1 (Fig. 3C).
The relative expression of the pluripotency marker genes
was determined for the piPS-H1 and the mESC lines using
quantitative real time polymerase chain reaction (qRT-PCR).
The housekeeping gene, GAPDH, was used as a reference.
The expression of all five pluripotency markers was slightly
higher for the piPS-H1 line compared to the control mESCs
(Fig. 3D).
To determine whether long-term culture affected the gene
expression of the five major pluripotency markers, we com-
pared the RNA expression level of the piPS-H1 line at early
(between passages 8–10) and later passages (between pas-
sages 22–25), respectively (Fig. 3E). No significant differences
in gene expression could be detected.
In vitro differentiation ability of piPSCs
In vitro differentiation assays were performed to assess the
in vitro developmental potential of the piPS-H1 line. Similar to
the control ESC line, the piPSC line was able to form embryoid
bodies (EBs) (Fig. 4A) under feeder-free culture conditions and
in the absence of leukemia inhibitory factor (LIF) (Fig. 4B).
To determine whether the piPS-H1 line could form cell
types of the three germ layers, EBs generated by hanging
drop technology were plated onto gelatin-coated plates and
FIG. 3. Characterization of piPSCs. (A) Immunostaining of piPSCs: At low passage number, the piPS-H1 line was positive
for all major pluripotency markers (SSEA1, Oct4, Sox2, Klf4, Nanog) by immunostaining. To visualize the nuclei, the cells
were counterstained with DAPI. Scale bar: 100 mm. (B) Determination of pluripotency markers by reverse transcription–
polymerase chain reaction (RT-PCR): Total RNA was isolated from cultured cells with the RNEasy Kit (Qiagen). One
microgram RNA was transcribed to cDNA using SuperScript III Reverse Transcriptase (Invitrogen). RT-PCRs were per-
formed using GoTaq Hot Start Green Master Mix (Promega). (C) Verification of pluripotency marker expression at higher
passage number ( p> 20) by immunostaining: After long-term culture of the piPS-H1 line, immunostaining was used to assess
expression of the pluripotency markers SSEA1, Oct4, Sox2 and Klf4. (D) Relative RNA expression of the major five pluripotency
markers for the piPS-H1 line was determined by quantitative real time polymerase chain reaction (qRT-PCR). The housekeeping
gene GAPDH was used as reference. (E) The relative RNA expression was not changed during long term culture. Data
presented as mean– SEM and included at least three independent experiments. The difference was considered significant for a
p£ 0.05. *p£ 0.05; **p< 0.001; ***p< 0.02; ****p< 0.01. Color images available online at www.liebertpub.com/tec
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cultured in ESC medium (EM) in the absence of LIF for a
further 7 days. The cells were collected and total RNA was
isolated and transcribed to cDNA. The expression of the
three germ layer markers was verified by reverse-transcrip-
tion PCR (Fig. 4C) and the relative RNA expression level was
determined by qRT-PCR (Fig. 4D–F). As NESTIN and
BRACHYURY T were also detected in the nondifferentiated
cells, we checked the rate of up-regulation of these markers
during differentiation. For BRACHYURY T (Fig. 4E) and
NESTIN (Fig. 4F), the relative RNA expression was highest
on D7 of differentiation, followed by a progressive decline.
For a-fetoprotein (Fig. 4D), the relative RNA expression in-
creased continuously until D21.
Because we plan to use the piPS-H1 line for drug selection
and for modeling human diseases in animal models, we in-
vestigated the cardiac and neural differentiation ability of
these cells. The differentiation assays were performed at both
early (between passages 8–10, Figs. 5 and 6) and later pas-
sages (between passages 22–25, data not shown) and no
significant differences could be detected.
Cardiac differentiation. After EB formation (day 2), each
individual EB was plated onto a single, gelatin coated well of
a 24-well plate in EM in the absence of LIF. Two days after
replating, 24/24 plated EBs were attached to the gelatin
coated surface. On day 6, 22/24 plated EBs started to beat; on
FIG. 4. In vitro differentia-
tion of piPS-H1 line. (A, B)
Embryoid body (EB) forma-
tion: In feeder-free conditions
both piPSC (A) and control
mESC (B) formed EBs. Scale
bar: 250mm. (C) Sponta-
neously differentiated and
nondifferentiated iPSCs and
control mESCs were collected
on day 7 of differentiation
and total RNA was isolated;
RNA was transcribed to
cDNA and the expression of
germ layer markers was ver-
ified by RT-PCR analysis. (D–
F) Relative RNA expression
of the three germ layer
markers detected during the
spontaneous differentiation
of piPS-H1 line. Data pre-
sented as mean– SEM and
included at least three inde-
pendent experiments. The
difference was considered
significant for a p £ 0.05.
*p< 0.001; **p< 0.03. Color
images available online at
www.liebertpub.com/tec
FIG. 5. Cardiac differentiation of piPSC and mESC. In vitro differentiation of piPSCs towards cardiac lineages: The EBs
obtained by hanging drop method were plated on day 2 of differentiation on gelatin coated coverslips and cultured further
until day 14 and 21 of differentiation. The EBs were stained for Desmin, a mesoderm marker, and for mature cardiomyocyte
marker, cardiac Troponin T (cTnT). Similar to the control ESCs (right panels), the new piPSC-derived cells (left panels) started
to beat on day 6 and was 98% on day 7. Scale bar 100 mm. Color images available online at www.liebertpub.com/tec
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FIG. 6. In vitro differentiation of the piPSCs towards neural lineages. (A) The cells were cultured in suspension for 8 days for
EB formation. On day 8, the EBs were trypsinized and seeded on poly-ornithine/laminin coated cover-slips and differen-
tiated further. The cells were probed for ectodermal markers on day 10, 12, and 14. The cells were Nestin- (characteristic
marker for neural progenitor cells [NPCs]) and III Tubulin- (Tuj 1; neuronal marker) positive. Scale bar 100 mm. (B) Flow
cytometry analysis of nestin positive NPCs. Color images available online at www.liebertpub.com/tec
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day 7, all 24 EBs were beating, similar to the control mESC
line. The EBs were cultured further, until day 14 and 21, and
then stained for cardiac troponin T, a mature cardiomyocyte
marker, and Desmin, a mesoderm marker. Both the piPSC
and control mESC lines were strongly positively stained for
these markers (Fig. 5).
Neural differentiation. The EBs generated by culturing
the cells in suspension for 8 days in bacterial (low attach-
ment) plates coated with 2-hydroxyethyl methacrylate, were
gently dissociated and replated on a poly-ornithin/laminin
coated surface in medium enriched with N2 culture sup-
plement and basic fibroblast growth factor. The medium was
changed the following day, and from day 10 the cells were
cultured in medium enriched with N2 and B27 supplements.
Two days after replating (day 10 of differentiation), the cells
started to develop neuronal morphology, and to form a
2D neural network. The cells were positive for Nestin, the
neural progenitor cell (NPC) marker, and for neural class III
b-Tubulin (Tuj1), a neuron marker (Fig. 6A), similar to the
marker patterns in the control cell line. This experiment
showed that piPSCs are able to generate NPCs and differen-
tiate further into matured neurons through EB formation in
cell culture. We quantified the amount of Nestin positive
NPCs by flow cytometry (Fig. 6B). On D10, 49–50% of the
analyzed cells were nestin positive. This ratio gradually de-
creased, and by D14 only 4–5% of the cells were nestin positive.
Chimera formation
The most important characteristic of veritable PSCs is the
ability to incorporate into the developing embryo. To assess
the ability of our piPS-H1 line (passage 8–9) to form chime-
ras, individual cells were injected into F1 (B6D2) hybrid
blastocysts. The adult mice that developed from these in-
jected embryos exhibited different degrees of chimerism,
demonstrated by the white coat color due to the piPS-H1
cells on the black coat color background of the host embryo
genotype (Fig. 7).
The results indicate that the piPS-H1 line can develop and
differentiate in vivo to generate adult chimeric mice.
Discussion
The aim of this study was to reprogram somatic cells using
a different approach to those published previously.44,45
During the preparation of this manuscript, another group
used an approach similar to ours to generate human iPSCs
(46). However, that group used multiple treatments to gen-
erate hiPSCs, transducing the cells daily with the purified
protein cocktail over a period of 17 days. In contrast, in our
experimental design the cells were treated only four times, at
48-h intervals.
The process of endocytosis, the major uptake mechanism
of the bioactive macromolecules carrying CPPs, is influenced
by numerous factors, including experimental conditions and
physicochemical properties of CPPs and their cargoes.51,52
Endocytosed biomolecules are often trapped in cell organ-
elles (vesicles, lysosomes, and endosomes), and contributed
to protein downregulation and elimination of misfolded
proteins. However, the escape of these proteins from the
organelles is essential for maintaining their biological activ-
ity. By using endosome disruptive peptides, triggered by
endosomal acidification, all or at least the majority of the
trapped proteins can escape. The presence of the NLS, or
some other peptides facilitate the cytosolic escape of the
trapped proteins; thus, preventing their degradation. Re-
cently, several membrane destabilizing peptides have been
derived,53 including the HA2 peptide from human influenza
virus, which both improves the cytosolic delivery of bio-
logical active molecules, and also enhances the cytotoxic
activity.54
Our recombinant proteins were fused in frame at the N
terminus to the TAT peptide sequence formed by positively
charged amino acids, with high arginine content, and to the
NLS sequence, which had a double role of supporting
the nuclear localization of the proteins, while minimizing the
endosomal/lysosomal trapping and ultimately the degra-
dation of the cargo.
The reprogramming experiments were carried out with
mouse fibroblasts from two different genetic backgrounds
(inbred [C57BL6] and outbred [ICR]). We were able to fully
reprogram fibroblasts from the outbred but not from the
inbred background. A possible explanation is that modifier
genes can act differently in different genetic backgrounds.
Phenotype penetrance is often influenced by genetic back-
ground, and the modulation of a given phenotype can be
diverse, as exemplified in the case of several mouse models
of human disease.55 iPSC generation can also be dependent
on genetic background and may differ from one strain to the
other as shown by our team24 using nonviral integrating
vectors. The other factor that may influence reprogramming
is the efficacy of protein transduction in inbred versus out-
bred strains.
Because the reprogramming efficacy of mouse and human
somatic cells has been reported to be improved under hyp-
oxic conditions,56 we performed the experiments at both
low (5%) and atmospheric O2 levels. Indeed, the number of
ES-like colonies obtained for both genetic backgrounds in-
creased considerably when the reprogramming was per-
formed under low O2 conditions (24 colonies for ICR and 18
for C57Bl6) compared to atmospheric O2 level conditions (8
colonies for ICR and 6 colonies for C57BL6). However, in
spite of the high number of colonies obtained under hypoxic
conditions, we couldn’t achieve full reprogramming of the
FIG. 7. Chimera formation.
Adult chimeras obtained by
blastocyst injection of piPS-
H1 cells. Color images avail-
able online at www
.liebertpub.com/tec
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genetic background, as the picked colonies flattened and
stopped multiplying after two to three passages. The efficacy
may also be influenced by the physico-chemical properties of
the purified recombinant proteins in the culture medium. It
has been reported that purified Oct4 has a limited solubility
and/or stability under certain cell culture conditions57 and
that the combination of 2% fetal calf serum and 7.5% serum
replacement increased the stability of Oct458 and Sox259 fu-
sion protein in the medium. The efficacy of reprogramming
is also affected by the protein concentration and the fre-
quency of the treatment.46 In several reprogramming sys-
tems, improvement was achieved by the addition of certain
small molecules.39,40 In view of these findings, further opti-
mization of the process to increase the reprogramming rate
may be possible.
The piPS-H1 line demonstrated similar morphology and
growth dynamics to the control ESCs, while qRT-PCR results
revealed a slightly increased relative RNA expression level of
all five pluripotency markers in the piPS-H1 line. OCT4 to-
gether with SOX2 and NANOG are important in maintaining
pluripotency and self-renewal, and it was shown recently
that a defined level of OCT4 is required.60 Once pluripotency
is established, the OCT4 level can decrease up to sevenfold
without losing the self-renewal properties in stem cells. As
these genes are acting together, the upregulation of one may
result in an increased gene expression for the others.
For the directed cardiac differentiation, we couldn’t detect
any significant difference from the day when the EBs started
to beat, as 24 out of 24 plated EBs formed by piPSC-H1 were
beating on day 7, similar to the mESC control. However,
there was a significant difference in neural fate commitment
of the control mESCs and the piPS-H1 cell line, with 80% of
the control cells (data not shown), but only 40–50% of the
piPS-H1 cells, positive by flow cytometry for the neural
precursor marker Nestin on day 10 (Fig. 6B). It has been
shown that ESC clones vary in their ability to differentiate
into neurons.61 The transcriptome analysis of these undif-
ferentiated ESC sublines also indicated differences in gene
expression even though all clones expressed pluripotency
markers. If there are substantial differences in the differen-
tiation ability of sublines generated from the same parental
ESC line, then it is possible that the differences in the neural
differentiation capability observed between the ESCs and
iPSCs might be ‘‘corrected’’ with generating and selecting
subclones of the H1 line.
Importantly, the piPSC-H1 cells could be incorporated
into blastocysts and form chimeras, proving that the cell line
could contribute to the development of the embryo proper.
We established this through coat color chimerism, a well-
accepted method. However, it is worth noting that cell lines
may exhibit distinct developmental potentials in vitro or
in vivo, and that one line may contribute to the development
of a given organ but not to others. Although we obtained
chimeras, we did not obtain germline transmission of the
piPS-H1 cell genetics for these animals; thus, the extent of
reprogramming of these cells is not entirely clear.
We have also generated miPSCs in our laboratory using
the non–viral reprogramming Sleeping Beauty transposon
system24 and a Cre recombinase excisable lentiviral system.
Although the iPSC lines generated with these two methods
performed better in vivo resulting in live born germline chi-
meras, their in vitro cardiac and neural differentiation ability
remained below the capacity observed for the piPS-H1 line
generated by protein transduction (data not shown).
In summary, we describe a noninvasive, transgene-free,
protein-mediated approach to reprogramming somatic cells.
This approach eliminates the potential risks associated with
the use of viruses, DNA transfection, and potentially harmful
chemicals and in the future could provide a safe source of
patient-specific cells for regenerative medicine. Further ex-
periments are now needed to increase the efficiency and re-
producibility of this approach, including its application in
human cell reprogramming, to make this iPSC generation
method more attractive as a method of choice.
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